Nonhedonic food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect

被引:324
作者
Volkow, ND [1 ]
Wang, GJ
Fowler, JS
Logan, J
Jayne, M
Franceschi, D
Wong, C
Gatley, SJ
Gifford, AN
Ding, YS
Pappas, N
机构
[1] Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA
[2] SUNY Stony Brook, Dept Psychiat, Stony Brook, NY 11794 USA
关键词
imaging; methylphenidate; nucleus accumbens; obesity; raclopride; D2; receptors;
D O I
10.1002/syn.10075
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The drive for food is one of the most powerful of human and animal behaviors. Dopamine, a neurotransmitter involved with motivation and reward, its believed to regulate food intake in laboratory animals by modulating its rewarding effects through the nucleus accumbens (NA). Here we assess the involvement of dopamine in "nonhedonic" food motivation in humans. Changes in extracellular dopamine in striatum in response to nonhedonic food stimulation (display of food without consumption) were evaluated in 10 food-deprived subjects 16-20 h) using positron emission tomography (PET) and [C-11]raclopride (a D2 receptor radioligand that competes with endogenous dopamine for binding to the receptor). To amplify the dopamine changes we pretreated subjects with methylphenidate (20 mg p.o.), a drug that blocks dopamine transporters (mechanism for removal of extracellular dopamine). Although the food stimulation when preceded by placebo did not increase dopamine or the desire for food, the food stimulation when preceded by methylphenidate (20 mg p.o.) did. The increases in extracellular dopamine were significant in dorsal (P < 0.005) but not in ventral striatum (area that included NA) and were significantly correlated with the increases in self-reports of hunger and desire for food (P < 0.01). These results provide the first evidence that dopamine in the dorsal striatum is involved in food motivation in humans that is distinct from its role in regulating reward through the NA. In addition it demonstrates the ability of methylphenidate to amplify weak dopamine signals. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:175 / 180
页数:6
相关论文
共 36 条
  • [1] Bassareo V, 1997, J NEUROSCI, V17, P851
  • [2] Modulation of feeding-induced activation of mesolimbic dopamine transmission by appetitive stimuli and its relation to motivational state
    Bassareo, V
    Di Chiara, G
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 1999, 11 (12) : 4389 - 4397
  • [3] QUANTITATION OF THE HUMAN BASAL GANGLIA WITH POSITRON EMISSION TOMOGRAPHY - A PHANTOM STUDY OF THE EFFECT OF CONTRAST AND AXIAL POSITIONING
    BENDRIEM, B
    DEWEY, SL
    SCHLYER, DJ
    WOLF, AP
    VOLKOW, ND
    [J]. IEEE TRANSACTIONS ON MEDICAL IMAGING, 1991, 10 (02) : 216 - 222
  • [4] What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
    Berridge, KC
    Robinson, TE
    [J]. BRAIN RESEARCH REVIEWS, 1998, 28 (03) : 309 - 369
  • [5] Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method
    Breier, A
    Su, TP
    Saunders, R
    Carson, RE
    Kolachana, BS
    de Bartolomeis, A
    Weinberger, DR
    Weisenfeld, N
    Malhotra, AK
    Eckelman, WC
    Pickar, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) : 2569 - 2574
  • [6] Expectation and dopamine release:: Mechanism of the placebo effect in Parkinson's disease
    de la Fuente-Fernández, R
    Ruth, TJ
    Sossi, V
    Schulzer, M
    Calne, DB
    Stoessl, AJ
    [J]. SCIENCE, 2001, 293 (5532) : 1164 - 1166
  • [7] STRIATAL BINDING OF THE PET LIGAND C-11 RACLOPRIDE IS ALTERED BY DRUGS THAT MODIFY SYNAPTIC DOPAMINE LEVELS
    DEWEY, SL
    SMITH, GS
    LOGAN, J
    BRODIE, JD
    FOWLER, JS
    WOLF, AP
    [J]. SYNAPSE, 1993, 13 (04) : 350 - 356
  • [8] Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial
    Efron, D
    Jarman, F
    Barker, M
    [J]. PEDIATRICS, 1997, 100 (04) : 662 - 666
  • [9] Files F.J., 1989, Behav Pharmacol, V1, P113
  • [10] Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
    Giros, B
    Jaber, M
    Jones, SR
    Wightman, RM
    Caron, MG
    [J]. NATURE, 1996, 379 (6566) : 606 - 612